Annual General Meeting of Kuros Biosciences approves all resolutions
Kuros Biosciences (SIX:KURN), a leader in next generation bone graft technologies, held its Annual General Meeting today…
Newsrooms
Kuros Biosciences's MagnetOs Granules cleared by FDA for expanded spinal indications
Rare clearance for bone graft for standalone use in spine based on human clinical data Clearance attained with evidence…
Kuros Biosciences wins 2020 Spine Technology Award from Orthopedics This Week
. Industry-leading award recognizes Kuros’ Fibrin-PTH (KUR-113) technology Rounds off successful year of commercial, c…
Neurotune Strengthens Management
Neurotune AG, a Swiss biopharmaceutical company, today announced personnel changes in its board of directors as well as…
